European Healthcare Investor Association (E.H.I.A.)

The aim of the European Healthcare Investor Association is provide networking and knowledge opportunities to our members, deliver sector focused market data and analysis, and promote a better understanding of investors’ contribution to the healthcare economy. Through discounts to sector events and complimentary access to our official journal, Investors in Healthcare, the potential financial value of benefits is greater than the annual membership fee. Investor Membership costs just £3,850 per year for an organisation, and the benefits are available to an unlimited number of team members. To explore the opportunities of membership, please contact our Executive Director Sarah Ward, sarah.ward@ehia.org #healthcare #lifesciences #pharma #investing #privateequity

EHIA Members: access your complimentary subscription to Investors in Healthcare To subscribe for free, request your access code from our Executive Director Sarah Ward sarah.ward@ehia.org Investors in Healthcare is a Google News approved digital resource delivering sector focussed news, data and analysis. It is the official journal of the European Healthcare Investor Association, the largest association of investors, senior managers and advisors in Europe focussed on building successful healthcare businesses. All EHIA Members are entitled to a complimentary subscription which provides full access to the entire news archive and data tables. (Value £295 per individual) To subscribe for free, request your access code from our Executive Director Sarah Ward sarah.ward@ehia.org #healthcare #lifesciences #pharma #investing #privateequity #news #data

The FairJourney Biologics Story: Andrea Ponti, Managing Partner and Founder GHO Capital Partners LLP (who are also Investor Members of European Healthcare Investor Association (E.H.I.A.)), led the investment in FairJourney which resulted in an approximately 10x return in four years. Andrea speaks exclusively to Nick Herbert, editor of the EHIA journal Investors in Healthcare about how in July, GHO sold a majority stake in Portugal-based CRO, FairJourney Biologics, to Swiss private equity firm Partners Group, while making a reinvestment alongside them and FairJourney founder and CEO António Parada. It partially brought an end to a relationship that saw GHO acquire a major stake in the biotech company in 2020. #privateequity #healthcare

Healthcare Market Insights: The latest ThinQ thoughts from EQT Group, an Investor Member of European Healthcare Investor Association (E.H.I.A.). In summary, the population is ageing, getting richer and fatter and the solutions are often tech enabled. #healthcare #insights

Germany: Investors in Healthcare Networking Dinner during Medica | 12 November 2024   European Healthcare Investor Association in association with strategic partner RSM Ebner Stolz Management Consultants is delighted to host an exclusive invitation-only dinner for healthcare investors on 12 November in Düsseldorf during MEDICA. Now an annual event, the dinner will be held in the historic Industrie-Club Düsseldorf and will provide an excellent opportunity for Private Equity investors and CEOs to network and discuss healthcare investment trends and opportunities. The dinner is on the second day of MEDICA, one of the largest medical technology trade fairs in the world with over 80,000 people and 4,500 exhibitors across digital health, medtech and devices, lab and diagnostics and more. Register your interest: https://lnkd.in/epeMqMxi #investing #healthcare #digitalhealth #medtech #medicaldevices #diagnostics Jannis Pulm Alexander Wenzel Dr. Sarah Gersch-Souvignet Pranshu Rohatgi Sarah Ward Henry Elphick Alan MacKay

Pharmathen Profile: Partners Group, an Investor Member of European Healthcare Investor Association (E.H.I.A.), acquired the company from BC Partners, another Investor Member. It is a leading developer and manufacturer of advanced drug delivery technologies that specialises in products that are so complex few others can make them. Its differentiated business model, along with its complex technology and experienced leadership team, sets it apart from other firms in the industry. WATCH the video below to hear how Partners Group has been working with Pharmathen's management team on key value creation initiatives to build the business. #privateequity #lifesciences Lauren Hasek Mark Hersee

Life Sciences Market Update: Latest deals in the venture and growth capital market for life sciences along with key people moves from Compass Carter Osborne, a strategic partner of European Healthcare Investor Association (E.H.I.A.) #lifesciences #venture Sam L. Matt Dixon

London: Life Sciences Investor Symposium: The second symposium for European Healthcare Investor Association (E.H.I.A.) partnering with Latham & Watkins and PwC following Paris in May and with Frankfurt to come on 16 September. REGISTER your interest here https://lw.link/zXGFoD Vice Chairs of Healthcare & Life Sciences Robbie McLaren and Eveline Van Keymeulen hosted panels providing perspectives on transaction best practices amid market shifts, navigating regulatory and competitive landscapes and identifying key investment opportunities: 🔺 Peter Stein, Chairman of Norgine, for an engaging keynote fireside chat 🔺 Neeshe Williams (Triton Partners owned Pharmanovia), Susanna El-Armale (Nordic Capital and Ontario Teachers' Pension Plan owned ADVANZ PHARMA), Alkesh Patel, Linzi Thomas, and Oliver Mobasser discussing transactions in turbulent times. 🔺 Marc Perkins (abcam), Ludmilla Le Grand, Emily Cridland, and David R. Little on the changing landscape and closing deals 🔺 William Deacon (AstraZeneca), Salim B. (Partners Group), Henry Elphick and Stephen Aherne on industry investment trends 🔺 Henrik Kjaer Hansen (Novo Holdings) and Dmitry (Dima) Podpolny (Bain & Company) for their outlook on the market #lifesciences #privateequity #healthcare Sarah Ward Dartmouth House Venue

Italy: Healthcare Investing Networking Dinner during CPHI, 8th October, Milan The European Healthcare Investor Association and Portolano Cavallo are hosting a CEO and Partner level dinner at the Museo Nazionale Scienza e Tecnologia "Leonardo da Vinci"in Milan.    The dinner will take place on the first day of CPHI, the world’s largest pharma event which brings together 47,000 professionals and 2,600 exhibitors from 150 countries. Riccardo Zagaria, CEO of DOC GENERICI (TPG owned Italian leading generics player), will join us for a fireside chat to discuss Italian Life Sciences trends and opportunities.  The evening will provide an excellent opportunity for Private Equity investors and CEOs to network and discuss investment trends and opportunities.   Please register your interest if you would like to join us: https://lnkd.in/eypiYa-t #lifesciences #pharma #privateequity #investing Francesco Portolano Andrea Gritti Luca Gambini Gianpaolo Scandone Alessandro Tanno Sarah Ward Henry Elphick Alan MacKay

Global: PE Capital Raising - Four of the top eight firms that have raised the most capital in the five years to March 2023 according to data from Private Equity International are members of the European Healthcare Investor Association (E.H.I.A.): ➡ EQT Group ➡ CVC ➡ Partners Group ➡ PAI Partners #privateequity #healthcare